Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.
DiNubile MJ, Chow JW, Satishchandran V, Polis A, Motyl MR, Abramson MA, Teppler H. DiNubile MJ, et al. Among authors: chow jw. Antimicrob Agents Chemother. 2005 Aug;49(8):3217-21. doi: 10.1128/AAC.49.8.3217-3221.2005. Antimicrob Agents Chemother. 2005. PMID: 16048928 Free PMC article. Clinical Trial.
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART).
Paterson DL, Rossi F, Baquero F, Hsueh PR, Woods GL, Satishchandran V, Snyder TA, Harvey CM, Teppler H, Dinubile MJ, Chow JW. Paterson DL, et al. Among authors: chow jw. J Antimicrob Chemother. 2005 Jun;55(6):965-73. doi: 10.1093/jac/dki117. Epub 2005 Apr 22. J Antimicrob Chemother. 2005. PMID: 15849262
Bowel colonization with vancomycin-resistant enterococci after antimicrobial therapy for intra-abdominal infections: observations from 2 randomized comparative clinical trials of ertapenem therapy.
DiNubile MJ, Friedland IR, Chan CY, Motyl MR, Giezek H, McCarroll K, Shivaprakash M, Quinn JP, Weinstein RA, Chow JW. DiNubile MJ, et al. Among authors: chow jw. Diagn Microbiol Infect Dis. 2007 Aug;58(4):491-4. doi: 10.1016/j.diagmicrobio.2007.03.016. Epub 2007 May 16. Diagn Microbiol Infect Dis. 2007. PMID: 17509789 Clinical Trial.
In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, Satishchandran V, McCarroll K, DiNubile MJ, Chow JW. Rossi F, et al. Among authors: chow jw. J Antimicrob Chemother. 2006 Jul;58(1):205-10. doi: 10.1093/jac/dkl199. Epub 2006 May 22. J Antimicrob Chemother. 2006. PMID: 16717055
In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
Hsueh PR, Snyder TA, Dinubile MJ, Satischandran V, McCarroll K, Chow JW; 2004 Asia-Pacific SMART Team. Hsueh PR, et al. Among authors: chow jw. Int J Antimicrob Agents. 2006 Sep;28(3):238-43. doi: 10.1016/j.ijantimicag.2006.04.010. Epub 2006 Aug 9. Int J Antimicrob Agents. 2006. PMID: 16904295
In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends).
Bochicchio GV, Baquero F, Hsueh PR, Paterson DL, Rossi F, Snyder TA, McCarroll K, Satishchandran V, Dinubile MJ, Chow JW. Bochicchio GV, et al. Among authors: chow jw. Surg Infect (Larchmt). 2006 Dec;7(6):537-45. doi: 10.1089/sur.2006.7.537. Surg Infect (Larchmt). 2006. PMID: 17233571
In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART).
Baquero F, Hsueh PR, Paterson DL, Rossi F, Bochicchio GV, Gallagher G, Lantz K, Villasenor JB, McCarroll K, Abramson MA, Chow JW. Baquero F, et al. Among authors: chow jw. Surg Infect (Larchmt). 2009 Apr;10(2):99-104. doi: 10.1089/sur.2008.0020. Surg Infect (Larchmt). 2009. PMID: 18831681
A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
Qin X, Tran BG, Kim MJ, Wang L, Nguyen DA, Chen Q, Song J, Laud PJ, Stone GG, Chow JW. Qin X, et al. Among authors: chow jw. Int J Antimicrob Agents. 2017 May;49(5):579-588. doi: 10.1016/j.ijantimicag.2017.01.010. Epub 2017 Mar 29. Int J Antimicrob Agents. 2017. PMID: 28363526 Free article. Clinical Trial.
201 results